Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Palma, David A.
Nguyen, Timothy K.
Louie, Alexander V.
Rodrigues, George B.
Dar, A. Rashid
Funding for this research was provided by:
Ontario Institute for Cancer Research